{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Uncontrolled+Seizures", "query": { "condition": "Uncontrolled Seizures" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Uncontrolled+Seizures&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-24T04:48:59.142Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02408523", "title": "A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Lacosamide Tablet", "type": "DRUG" }, { "name": "Lasosamide Oral Solution", "type": "DRUG" }, { "name": "Placebo Tablet", "type": "OTHER" }, { "name": "Placebo Oral Solution", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UCB BIOSCIENCES, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 242, "start_date": "2015-04", "completion_date": "2019-06", "has_results": true, "last_update_posted_date": "2020-12-17", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 27, "location_summary": "Alabaster, Alabama • Little Rock, Arkansas • Irvine, California + 23 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02408523" }, { "nct_id": "NCT01118949", "title": "Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Lacosamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB BIOSCIENCES, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "16 Years to 65 Years" }, "enrollment_count": 49, "start_date": "2010-05", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2018-07-17", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 25, "location_summary": "Alabaster, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 22 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01118949" }, { "nct_id": "NCT00512317", "title": "Open-label Extension to Protocol 1042-0600", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epilepsies, Partial" ], "interventions": [ { "name": "ganaxolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Marinus Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 123, "start_date": "2007-06", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2023-01-17", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00512317" }, { "nct_id": "NCT01484977", "title": "eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Lacosamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2011-12", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2018-07-18", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 30, "location_summary": "Huntsville, Alabama • Phoenix, Arizona • Fresno, California + 27 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Oxnard", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01484977" }, { "nct_id": "NCT03116828", "title": "A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Epilepsy With Partial On-set Seizures" ], "interventions": [ { "name": "Eslicarbazepine Acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 102, "start_date": "2017-07-07", "completion_date": "2019-06-06", "has_results": true, "last_update_posted_date": "2020-06-16", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 53, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Downey, California + 46 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Downey", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03116828" }, { "nct_id": "NCT00465517", "title": "A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Partial Epilepsy", "Catamenial Epilepsy" ], "interventions": [ { "name": "Ganaxolone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Marinus Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 147, "start_date": "2007-02", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2023-03-15", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00465517" }, { "nct_id": "NCT02408549", "title": "Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Lacosamide Tablet", "type": "DRUG" }, { "name": "Lacosamide Oral Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB BIOSCIENCES, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": null, "sex": "ALL", "summary": "4 Years and older" }, "enrollment_count": 239, "start_date": "2015-08-03", "completion_date": "2023-03-30", "has_results": true, "last_update_posted_date": "2023-12-14", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 16, "location_summary": "Little Rock, Arkansas • Santa Monica, California • Colorado Springs, Colorado + 13 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Santa Monica", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Loxahatchee Groves", "state": "Florida" }, { "city": "Panama City", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02408549" }, { "nct_id": "NCT07663240", "title": "Epilepsy Emergency Department High Utilizer Program", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Epilepsy", "Uncontrolled Seizures" ], "interventions": [ { "name": "CHW-Led Transition-of-Care Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Morehouse School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 15, "start_date": "2026-05-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07663240" }, { "nct_id": "NCT00044278", "title": "Pediatric Epilepsy Study in Subjects 1-24 Months", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "lamotrigine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "24 Months", "sex": "ALL", "summary": "1 Month to 24 Months" }, "enrollment_count": 197, "start_date": "2000-09", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 41, "location_summary": "Mobile, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 36 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00044278" }, { "nct_id": "NCT01118962", "title": "Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Lacosamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB BIOSCIENCES, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "16 Years to 65 Years" }, "enrollment_count": 39, "start_date": "2010-08", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2018-07-17", "last_synced_at": "2026-07-24T04:48:59.142Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Aurora, Colorado + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boise", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT01118962" } ] }